<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Limited has filed its annual disclosure under SEBI regulations for Large Corporate entities. The company clarified it does not fall under the Large Corporate category as per SEBI's circular on fund-raising through debt securities. For FY 2025-26, no mandatory borrowing through debt securities was applicable and actual borrowing was nil. No penalties were applicable. The disclosure was signed by Company Secretary Kumkum Bajaj on April 27, 2026. The company is a subsidiary of Virupaksha Organics Limited.
This is a routine compliance filing confirming the company's non-classification as a Large Corporate. There is no impact on shareholders or stock price as this merely establishes the company does not meet the threshold criteria for large corporate debt issuance requirements.